Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares
AI-generated summary
Officer and Director MATTHEW ADAM GLINE of Roivant Sciences Ltd. proposed to sell 164,136 common shares with an aggregate market value of $6,729,576 through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were acquired as Performance Stock Units on November 10, 2026. The proposed sale date is November 10, 2026.
Key facts
- Seller
- MATTHEW ADAM GLINE
- Relationship
- Officer, Director
- Shares to sell
- 164,136
- Market value
- $6,729,576.00
- Approximate sale date
- Nov 10, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 10, 2026 · Performance Stock Units
More ROIV filings
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.